Healthcare professionals should consider alternatives to Tygacil in patients with severe infections.
|
9/1/2010 2:00:00 PM |
Risk of infection, damage or death of tissue, swelling, or other serious adverse health consequences occurring as a result of the core travelling through blood vessels into the patient’s lungs.
|
8/26/2010 7:40:00 PM |
Increase in reports of bloodborne infection transmission resulting from the shared use of fingerstick and point-of-care blood testing devices.
|
8/26/2010 6:30:00 PM |
Product marketed as dietary supplement contains undeclared hydroxythiohomosildenafil, a chemical similar to sildenafil, which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels.
|
8/25/2010 7:25:00 PM |
Customers asked to immediately quarantine the use of affected lots due to the potential for serious thromboembolic events.
|
8/25/2010 3:00:00 PM |
Product marketed as dietary supplement contains undeclared hydroxythiohomosildenafil and sulfoaildenafil, which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels.
|
8/24/2010 3:15:00 PM |
Potential for failure of a pressure switch, which may have an impact on the administration of INOMAX for inhalation to patients.
|
8/24/2010 12:50:00 AM |
FDA evaluating clinical trial data that suggest patients taking drug may be at an increased risk for cardiovascular events
compared to those taking carbidopa/levodopa
|
8/20/2010 4:00:00 AM |
Companies failed to provide evidence of clinical benefit of midodrine hydrochloride because required post-approval studies that verify the clinical benefit of the drug have not been done.
|
8/16/2010 7:45:00 PM |
Potentially life threatening episode of bleeding could occur during surgical procedures.
|
8/13/2010 6:35:00 PM |
Product marketed as dietary supplement contains undeclared sulfoaildenafil, which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels.
|
8/13/2010 1:55:00 PM |
Warnings and Precautions section of Prescribing Information and patient Medication Guide revised to include information about the risk of aseptic meningitis.
|
8/12/2010 7:14:00 PM |
Products marketed as dietary supplement sexual enhancers for men contain undeclared sulfoaildenafil, which may interact with nitrates found in some prescription drugs such as nitroglycerin and may lower blood pressure to dangerous levels.
|
8/11/2010 6:00:00 PM |
Suspected counterfeit product is weaker, and breaks or bends before necessary force can be applied to stop blood flow. Excessive blood loss can endanger the victim’s life and ultimately lead to death.
|
8/9/2010 5:30:00 PM |
Known long term risks associated with IVC filters include lower limb deep vein thrombosis, filter fracture, filter migration, filter embolization and IVC perforation.
|
8/9/2010 3:20:00 PM |
Product contains undeclared
didesmethyl sibutramine, which may present a significant risk for patients with a history of coronary artery disease, congestive heart
failure, arrhythmias or stroke.
|
8/9/2010 1:25:00 PM |
Product marketed as a dietary supplement sexual enhancer for men contains undeclared tadalafil, which may interact with nitrates found in some prescription drugs such as nitroglycerin and may lower blood pressure to dangerous levels.
|
8/9/2010 1:05:00 PM |
IV injection can result in cardiac arrest, severe falls in blood pressure, and other heart-related complications.
|
8/2/2010 7:40:00 PM |
Potential for particulate matter to result in serious adverse effects.
|
8/2/2010 5:35:00 PM |
Increased incidence of fever and febrile seizure among young children reported in Australia, mainly among those less than 5 years of age.
|
7/31/2010 12:54:00 AM |
Product sold online as a dietary supplement. When consumed as instructed, produces an industrial bleach that can cause serious harm to health.
|
7/30/2010 10:30:00 PM |
These products, marketed as dietary supplements, contain sulfoaildenafil, which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerously low levels.
|
7/30/2010 8:20:00 PM |
Reports of adverse effects in children who may have been unintentionally exposed to the drug through skin contact with women using this product.
|
7/29/2010 6:00:00 PM |
Cases of serious, potentially fatal pneumonia associated with the IV antibacterial drug Cubicin.
|
7/29/2010 2:00:00 PM |
Product contains sibutramine; may increase blood pressure/pulse rate with risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, stroke.
|
7/22/2010 4:00:00 AM |
